New Zealand's Southern District Health Region Adopts Pacific Edge’s Cxbladder Tests
Pacific Edge today announces it has substantially completed a commercial agreement with the New Zealand Southern District Health Region (SDHR) for the use of its non-invasive... read more
Smoking and Bladder Cancer
You may know that cigarette smoking is the leading cause of preventable disease and death in the US, but did you know that smoking is also... read more
New News Detail Page
*You are invited to learn about the real life impact of Cxbladder tests on diagnosis and surveillance of bladder cancer* Cxbladder would like to invite you to... read more
New Page
The adoption of Cxbladder Triage in primary care read more
Enhanced Cxbladder Tests Deliver Improved Diagnostic Performance
Pacific Edge today announces the acceptance for publication of new clinical evidence that shows significant improvements in the performance of its genomic diagnostic Cxbladder tests. These... read more
Te Whatu Ora - Southern Commercial Agreement Completed
On the 21st July 2022, Pacific Edge announced that it had substantially completed a commercial agreement with Te Whatu Ora – Southern for the use of... read more
Inspirational Films for Cancer Patients and Survivors
Film can be a powerful medium for those coming to terms with a cancer diagnosis and the uncertainty it brings. Stories of strength, determination, hope and... read more
2023
Study Adds Support for Cxbladder Monitor Use in Cancer Surveillance
Pacific Edge today welcomes the release of new research supporting the clinical utility of the company’s genomic biomarker test Cxbladder Monitor in the surveillance for bladder... read more
Pacific Edge to Showcase Leading Biomarker Strategies for the Evaluation and Management of Bladder C
Pacific Edge today announces its key activities and highlights at the 87th Annual AUA Southeastern Section (SESAUA) meeting to be held March 15-18 in Amelia Island,... read more